Systemic lupus erythematosus-associated lymphoproliferative disorder: Report of a case and discussion in light of the literature

被引:23
作者
Blanco, R
McLaren, B
Davis, B
Steele, P
Smith, R
机构
[1] Dept. of Pathol. and Lab. Medicine, Univ. of Cincinnati Medical College, Cincinnati, OH
[2] Dept. of Pathol. and Lab. Medicine, Univ. of Cincinnati Medical College, 1358F Medical Sciences Building, Cincinnati, OH 45267-0529
关键词
systemic lupus erythematosus; lymphadenopathy; lymphoproliferative disorder; thymic hyperplasia;
D O I
10.1016/S0046-8177(97)90015-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A case of autoimmune disease-associated lymphadenopathy (ADAL) with histological, immunophenotypic, Epstein-Barr virus (EBV) in situ hybridization, and genotypic analyses is presented. The patient had a well-documented history of systemic lupus erythematosus (SLE) and was found at autopsy to have massive lymphadenopathy, thymic enlargement, pulmonary nodules, and polyclonal serum dysproteinemia. Histological examination revealed a polymorphous lymphoid infiltrate containing many plasma cells, rare immunoblasts, and a pronounced arborizing vasculature. No foci of necrosis were found and there was no evidence of lymphocyte depletion. The plasma cells were immunophenotypically polyclonal and no EBV mRNA (EBER-1) or gene rearrangements were identified. The unusual gross features, which resembled a malignant lymphoproliferative process, as well as the unusual histological features make this case a notable addition to the spectrum of atypical lymphoproliferative disorders associated with an autoimmune disorder. We conclude that although reminiscent of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD), this case lacks: the diagnostic features of AILD, and is, perhaps, best classified as an autoimmune disease-associated lymphadenopathy (ADAL). (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:980 / 985
页数:6
相关论文
共 32 条
[1]   B-CELL LYMPHOMA AFTER ANGIOIMMUNOBLASTIC LYMPHADENOPATHY - A CASE WITH OLIGOCLONAL GENE REARRANGEMENTS ASSOCIATED WITH EPSTEIN-BARR-VIRUS [J].
ABRUZZO, LV ;
SCHMIDT, K ;
WEISS, LM ;
JAFFE, ES ;
MEDEIROS, LJ ;
SANDER, CA ;
RAFFELD, M .
BLOOD, 1993, 82 (01) :241-246
[2]  
ANAZAI T, 1994, JAPANESE J CLIN ONCO, V24, P106
[3]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[4]  
Fox RA, 1943, AM J PATHOL, V19, P73
[5]   ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY - DIAGNOSIS AND CLINICAL COURSE [J].
FRIZZERA, G ;
MORAN, EM ;
RAPPAPORT, H .
AMERICAN JOURNAL OF MEDICINE, 1975, 59 (06) :803-818
[6]  
FRIZZERA G, 1981, CANCER RES, V41, P4262
[7]  
FRIZZERA G, 1992, NEOPLASTIC HEMATOPAT, P459
[8]   EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B-CELL LYMPHOPROLIFERATION [J].
HANTO, DW ;
FRIZZERA, G ;
GAJLPECZALSKA, KJ ;
SIMMONS, RL .
TRANSPLANTATION, 1985, 39 (05) :461-472
[9]  
HIETER PA, 1982, J BIOL CHEM, V257, P1516
[10]   REVERSIBLE LYMPHOMAS ASSOCIATED WITH EPSTEIN-BARR-VIRUS OCCURRING DURING METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS AND DERMATOMYOSITIS [J].
KAMEL, OW ;
VANDERIJN, M ;
WEISS, LM ;
DELZOPPO, GJ ;
HENCH, PK ;
ROBBINS, BA ;
MONTGOMERY, PG ;
WARNKE, RA ;
DORFMAN, RF .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1317-1321